Ad is loading...
JCLCX
Price
$11.92
Change
-$0.02 (-0.17%)
Updated
Nov 15 closing price
PACAX
Price
$10.92
Change
-$0.06 (-0.55%)
Updated
Nov 15 closing price
Ad is loading...

JCLCX vs PACAX

Header iconJCLCX vs PACAX Comparison
Open Charts JCLCX vs PACAXBanner chart's image
JHancock Multimanager Lifestyle Cnsrv C
Price$11.92
Change-$0.02 (-0.17%)
VolumeN/A
CapitalizationN/A
Putnam Dynamic Asset Allocation Cnsrv A
Price$10.92
Change-$0.06 (-0.55%)
VolumeN/A
CapitalizationN/A
JCLCX vs PACAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JCLCX vs. PACAX commentary
Nov 16, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JCLCX is a Hold and PACAX is a StrongBuy.

FUNDAMENTALS
Fundamentals
JCLCX has more cash in the bank: 1.65B vs. PACAX (576M). JCLCX pays higher dividends than PACAX: JCLCX (2.84) vs PACAX (2.18). JCLCX was incepted earlier than PACAX: JCLCX (19 years) vs PACAX (31 years). PACAX is a more actively managed with annual turnover of: 456.00 vs. JCLCX (15.00). PACAX has a lower initial minimum investment than JCLCX: PACAX (0) vs JCLCX (1000). PACAX annual gain was more profitable for investors over the last year : 16.76 vs. JCLCX (10.75). PACAX return over 5 years is better than : 11.40 vs. JCLCX (3.25).
JCLCXPACAXJCLCX / PACAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence19 years31 years-
Gain YTD5.39710.12353%
Front LoadN/AN/A-
Min. Initial Investment10000-
Min. Initial Investment IRA1000N/A-
Net Assets1.65B576M287%
Annual Yield % from dividends2.842.18130%
Returns for 1 year10.7516.7664%
Returns for 3 years-6.50-2.74237%
Returns for 5 years3.2511.4029%
Returns for 10 years5.8815.3938%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GPGCX16.980.11
+0.65%
Grandeur Peak Global Contrarian Instl
JHLVX62.38N/A
N/A
JHancock Fundamental Large Cap Core C
FIUSX38.16N/A
N/A
Delaware Opportunity A
NSFEX11.43-0.04
-0.35%
Natixis Target Retirement 2025 N
ETNHX34.80-0.82
-2.30%
Eventide Healthcare & Life Sciences N